Followers | 130 |
Posts | 14996 |
Boards Moderated | 1 |
Alias Born | 06/04/2018 |
Monday, August 17, 2020 2:00:51 PM
NEW YORK, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James F. Oliviero, President and Chief Executive Officer, will present a company overview...
Read the whole news CKPT - Checkpoint Therapeutics to Present at Virtual Corporate Access Summit Hosted by B. Riley FBR on Wednesday, August 19, 2020
Recent CKPT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 01:30:12 AM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/05/2024 10:00:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2024 01:15:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 10:15:50 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/30/2024 10:10:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 10:00:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 10:01:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 12:10:40 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/17/2023 10:02:12 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/17/2023 10:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 10:15:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 10:10:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 09:00:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:36:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:30:46 PM
- Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 08/14/2023 08:01:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 12:28:56 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/31/2023 12:23:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/27/2023 11:30:13 AM
- Fortress Biotech Reports First Quarter 2023 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 05/15/2023 08:01:31 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM